Cargando…

A combined biomarker panel shows improved sensitivity and specificity for detection of ovarian cancer

BACKGROUND: Combined biomarkers can improve the sensitivity and specificity of ovarian cancer (OC) diagnosis and effectively predict patient prognosis. This study explored the diagnostic and prognostic values of serum CCL18 and CXCL1 antigens combined with C1D, FXR1, ZNF573, and TM4SF1 autoantibodie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Lu, Tang, Yong, Deng, Ming‐jing, Huang, Chun‐tao, Lan, Dong, Nong, Wen‐Zheng, Li, Li, Wang, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842139/ https://www.ncbi.nlm.nih.gov/pubmed/34995016 http://dx.doi.org/10.1002/jcla.24232

Ejemplares similares

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours
por: Russell, Matthew R, et al.
Publicado: (2017)

Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel
por: Russell, Matthew R., et al.
Publicado: (2019)

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
por: Lind, Guro E, et al.
Publicado: (2011)

Platelet protein biomarker panel for ovarian cancer diagnosis
por: Lomnytska, Marta, et al.
Publicado: (2018)

Biological Diagnosis of Depression: A Biomarker Panel from Several Nonspecial Indicators Instead of the Specific Biomarker(s)
por: Li, Jia-Mei, et al.
Publicado: (2022)

Multi-biomarker panel signature as the key to diagnosis of ovarian cancer
por: Muinao, Thingreila, et al.
Publicado: (2019)

New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer
por: Yuan, Wei, et al.
Publicado: (2016)

Panel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer
por: Zhan, Xiaohui, et al.
Publicado: (2017)

Combined Application of NMR- and GC-MS-Based Metabonomics Yields a Superior Urinary Biomarker Panel for Bipolar Disorder
por: Chen, Jian-jun, et al.
Publicado: (2014)

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
por: Oikonomopoulou, K, et al.
Publicado: (2008)

Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer
por: Walker, Christopher, et al.
Publicado: (2021)

Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer
por: Tang, Ying, et al.
Publicado: (2020)

Screening and prognostic value of potential biomarkers for ovarian cancer
por: Li, Huiqin, et al.
Publicado: (2021)

A Panel of DNA Methylation and Proteomic Biomarkers for Specific Aging Pathways
por: Higgins-Chen, Albert, et al.
Publicado: (2020)

Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers
por: Kamble, Swapnil C., et al.
Publicado: (2019)

A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes
por: Li, Qi, et al.
Publicado: (2022)

A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma
por: Zhi, Feng, et al.
Publicado: (2016)

A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer
por: Deng, Benyuan, et al.
Publicado: (2020)

Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study
por: Jensen, Sarah Østrup, et al.
Publicado: (2019)

Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma
por: Tsou, Jeffrey A, et al.
Publicado: (2007)

Extracellular-Vesicle-Based Cancer Panels Diagnose Glioblastomas with High Sensitivity and Specificity
por: Mut, Melike, et al.
Publicado: (2023)

Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts
por: Guffanti, Federica, et al.
Publicado: (2018)

A Panel of Serum MicroRNAs as Specific Biomarkers for Diagnosis of Compound- and Herb-Induced Liver Injury in Rats
por: Su, Yu-Wen, et al.
Publicado: (2012)

Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease
por: Zeng, Yuping, et al.
Publicado: (2022)

Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis
por: Govers, Tim M., et al.
Publicado: (2023)

Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer
por: Koh, Stephen Chee Liang, et al.
Publicado: (2012)

Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2017)

Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2017)

Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
por: Kim, Hongbeom, et al.
Publicado: (2020)

Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer
por: Ali, Fahmy T., et al.
Publicado: (2022)

A pair of SARS-CoV-2 nucleocapsid protein monoclonal antibodies shows high specificity and sensitivity for diagnosis
por: Zhu, An-Kai, et al.
Publicado: (2022)

Serum biomarker panel for disease severity and prognosis in patients with COVID‐19
por: Li, Jing, et al.
Publicado: (2023)

Sensitivity and specificity of DPP(®) Fever Panel II Asia in the diagnosis of malaria, dengue and melioidosis
por: Amornchai, Premjit, et al.
Publicado: (2022)

Serum biomarker panels for the diagnosis of gastric cancer
por: Wu, Dan, et al.
Publicado: (2019)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
por: Della Pepa, Chiara, et al.
Publicado: (2014)

Serum biomarker panels for diagnosis of gastric cancer
por: Tong, Weihua, et al.
Publicado: (2016)

Differentiating heart failure phenotypes using sex‐specific transcriptomic and proteomic biomarker panels
por: Toma, Mustafa, et al.
Publicado: (2017)

A combined biomarker and clinical panel for chronic graft versus host disease diagnosis
por: Pidala, Joseph, et al.
Publicado: (2016)

Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy
por: Kruger, Deirdré, et al.
Publicado: (2019)

Including Fibroblast Growth Factor-21 in Combined Biomarker Panels Improves Predictions of Liver Steatosis Severity in Children
por: Hua, Man-Chin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mf6g3da0ffljdb1ukld6v62m3d